Skip to Content
Merck
  • Precise control of miR-125b levels is required to create a regeneration-permissive environment after spinal cord injury: a cross-species comparison between salamander and rat.

Precise control of miR-125b levels is required to create a regeneration-permissive environment after spinal cord injury: a cross-species comparison between salamander and rat.

Disease models & mechanisms (2014-04-11)
Juan Felipe Diaz Quiroz, Eve Tsai, Matthew Coyle, Tina Sehm, Karen Echeverri
ABSTRACT

Most spinal cord injuries lead to permanent paralysis in mammals. By contrast, the remarkable regenerative abilities of salamanders enable full functional recovery even from complete spinal cord transections. The molecular differences underlying this evolutionary divergence between mammals and amphibians are poorly understood. We focused on upstream regulators of gene expression as primary entry points into this question. We identified a group of microRNAs (miRNAs) that are conserved between the Mexican axolotl salamander (Ambystoma mexicanum) and mammals but show marked cross-species differences in regulation patterns following spinal cord injury. We found that precise post-injury levels of one of these miRNAs (miR-125b) is essential for functional recovery, and guides correct regeneration of axons through the lesion site in a process involving the direct downstream target Sema4D in axolotls. Translating these results to a mammalian model, we increased miR-125b levels in the rat through mimic treatments following spinal cord transection. These treatments downregulated Sema4D and other glial-scar-related genes, and enhanced the animal's functional recovery. Our study identifies a key regulatory molecule conserved between salamander and mammal, and shows that the expression of miR-125b and Sema4D must be carefully controlled in the right cells at the correct level to promote regeneration. We also show that these molecular components of the salamander's regeneration-permissive environment can be experimentally harnessed to improve treatment outcomes for mammalian spinal cord injuries.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glutaraldehyde solution, technical, ~50% in H2O (5.6 M)
Supelco
Benzocaine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Glutaraldehyde solution, 50 wt. % in H2O
Sigma-Aldrich
Glutaric dialdehyde solution, 50 wt. % in H2O, FCC
Sigma-Aldrich
Glutaraldehyde solution, Grade I, 8% in H2O, specially purified for use as an electron microscopy fixative or other sophisticated use
Sigma-Aldrich
Glutaraldehyde solution, Grade I, 70% in H2O, specially purified for use as an electron microscopy fixative or other sophisticated use
Sigma-Aldrich
Glutaraldehyde solution, 50% in H2O, suitable for photographic applications
Sigma-Aldrich
Benzocaine, ≥99% (HPLC)
Sigma-Aldrich
Glutaraldehyde solution, Grade I, 25% in H2O, specially purified for use as an electron microscopy fixative
Sigma-Aldrich
Glutaraldehyde solution, Grade I, 50% in H2O, specially purified for use as an electron microscopy fixative or other sophisticated use
Sigma-Aldrich
Glutaraldehyde solution, Grade II, 25% in H2O
USP
Benzocaine, United States Pharmacopeia (USP) Reference Standard
Benzocaine, European Pharmacopoeia (EP) Reference Standard
Supelco
Benzyl benzoate, analytical standard
Sigma-Aldrich
Benzyl benzoate, ≥99%, FCC, FG
Sigma-Aldrich
Benzyl benzoate, natural, ≥99%, FG
Sigma-Aldrich
Benzyl benzoate, tested according to Ph. Eur.
Sigma-Aldrich
Benzyl benzoate, meets USP testing specifications
Supelco
Benzyl benzoate, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ethyl 4-aminobenzoate, 98%
Sigma-Aldrich
Benzyl benzoate, ReagentPlus®, ≥99.0%
USP
Benzyl benzoate, United States Pharmacopeia (USP) Reference Standard